1. Home
  2. THAR vs JCSE Comparison

THAR vs JCSE Comparison

Compare THAR & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • JCSE
  • Stock Information
  • Founded
  • THAR 2017
  • JCSE 1999
  • Country
  • THAR United States
  • JCSE Singapore
  • Employees
  • THAR N/A
  • JCSE N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • JCSE Miscellaneous manufacturing industries
  • Sector
  • THAR Health Care
  • JCSE Consumer Discretionary
  • Exchange
  • THAR Nasdaq
  • JCSE Nasdaq
  • Market Cap
  • THAR 5.5M
  • JCSE 5.9M
  • IPO Year
  • THAR 2022
  • JCSE 2022
  • Fundamental
  • Price
  • THAR $1.46
  • JCSE $1.07
  • Analyst Decision
  • THAR Strong Buy
  • JCSE
  • Analyst Count
  • THAR 1
  • JCSE 0
  • Target Price
  • THAR $17.00
  • JCSE N/A
  • AVG Volume (30 Days)
  • THAR 43.3K
  • JCSE 6.0K
  • Earning Date
  • THAR 08-08-2025
  • JCSE 05-15-2025
  • Dividend Yield
  • THAR N/A
  • JCSE 8.41%
  • EPS Growth
  • THAR N/A
  • JCSE N/A
  • EPS
  • THAR N/A
  • JCSE 0.00
  • Revenue
  • THAR N/A
  • JCSE $14,126,397.00
  • Revenue This Year
  • THAR N/A
  • JCSE N/A
  • Revenue Next Year
  • THAR N/A
  • JCSE N/A
  • P/E Ratio
  • THAR N/A
  • JCSE $238.19
  • Revenue Growth
  • THAR N/A
  • JCSE 6.92
  • 52 Week Low
  • THAR $0.95
  • JCSE $0.86
  • 52 Week High
  • THAR $6.39
  • JCSE $2.39
  • Technical
  • Relative Strength Index (RSI)
  • THAR 39.40
  • JCSE 47.56
  • Support Level
  • THAR $1.60
  • JCSE $1.04
  • Resistance Level
  • THAR $1.75
  • JCSE $1.10
  • Average True Range (ATR)
  • THAR 0.10
  • JCSE 0.04
  • MACD
  • THAR -0.04
  • JCSE 0.00
  • Stochastic Oscillator
  • THAR 1.01
  • JCSE 27.78

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.

Share on Social Networks: